When did ClearPoint Neuro report Q2 2025 earnings?

ClearPoint Neuro (CLPT) reported Q2 2025 earnings on August 12, 2025 after market close.

What were ClearPoint Neuro's Q2 2025 revenue and EPS?

ClearPoint Neuro reported revenue of $9.2M and diluted EPS of $-0.21 for Q2 2025.

Did ClearPoint Neuro beat estimates in Q2 2025?

Revenue missed the consensus estimate of $9.8M by $585.0K. EPS missed the consensus estimate of $-0.20 by $0.01.

How did ClearPoint Neuro's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 17.3% from $7.9M a year earlier and diluted EPS declined 31.2% from $-0.16.

Where can I find ClearPoint Neuro's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001285550-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.

ClearPoint Neuro CLPT Q2 2025 earnings

Reported August 12, 2025 · After market close

Revenue$9.2MMiss by $585.0K Diluted EPS-$0.21Miss by $0.01

Revenue estimate$9.8M

EPS estimate-$0.20

Next report

Aug 11, 2026 (in a month)

Revenue estimate$12.7M

EPS estimate-$0.27

Financials

Q2 2025

Income statement

See full

Revenue$9.2M+17.3%

Gross profit$5.6M+11.4%

Operating income-$5.7M-20.2%

Net income-$5.8M-32.4%

EPS (diluted)-$0.21-31.2%

Balance sheet

See full

Cash & equivalents$41.7M+27.0%

Total debt$35.5M+157%

Total equity$19.7M-38.6%

Total assets$62.9M+19.6%

Cash flow

See full

Operating cash flow-$2.6M+4.3%

CapEx$91.0K—

Free cash flow-$2.6M+0.9%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$328.72M+122%

Enterprise value$322.46M+150%

P/S9.8×+4.5×

Profitability

See full

Gross margin60.4%+0.6pp

Operating margin-67.4%+1.4pp

Net margin-66.2%+2.2pp

FCF margin-34.9%+0.2pp

Returns & leverage

See full

Return on equity-85.7%+61.7pp

Debt / equity1.8×+1.4×

Current ratio7.3×+4.5×

Segments

By product

See full

Biologics And Drug Delivery$4.7M+9.5%

Neurosurgery Navigation And Therapy$3.4M+32.7%

Neurosurgery Navigation And Therapy Disposable Products$3.4M+32.7%

Biologics And Drug Delivery Services And License Fees$2.9M+8.0%

Biologics And Drug Delivery Disposable Products$1.9M+12.0%

Versus estimates

Revenue

Q1 2026$12.1MBeat by $161.3K Q4 2025$10.4MBeat by $350.0K Q3 2025$8.9MMiss by $1.5M

Q2 2025$9.2MMiss by $585.0K

Q1 2025$8.5MMiss by $681.7K Q4 2024$7.8MMiss by $458.7K

Diluted EPS

Q1 2026-$0.32Miss by $0.04 Q4 2025-$0.27Miss by $0.05 Q3 2025-$0.21Miss by $0.01

Q2 2025-$0.21Miss by $0.01

Q1 2025-$0.22Miss by $0.07 Q4 2024-$0.20Miss by $0.05

Ask the moment ClearPoint Neuro reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did ClearPoint Neuro report Q2 2025 earnings?: ClearPoint Neuro (CLPT) reported Q2 2025 earnings on August 12, 2025 after market close.
What were ClearPoint Neuro's Q2 2025 revenue and EPS?: ClearPoint Neuro reported revenue of $9.2M and diluted EPS of $-0.21 for Q2 2025.
Did ClearPoint Neuro beat estimates in Q2 2025?: Revenue missed the consensus estimate of $9.8M by $585.0K. EPS missed the consensus estimate of $-0.20 by $0.01.
How did ClearPoint Neuro's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 17.3% from $7.9M a year earlier and diluted EPS declined 31.2% from $-0.16.
Where can I find ClearPoint Neuro's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001285550-25-000012) directly on SEC EDGAR. The filing index links above go to sec.gov.